QQ客服 官方微博 反馈留言

	Comparison of six cycles of epirubicin and paclitaxel (ET) versus four cycles of epirubicin and cyclophosphamide, followed by four cycles of paclitaxel (EC-T) as adjuvant therapy for operable breast cancer in women with positive axillary nodes
	Yuan, Peng; Wang, Jiayu; Ma, Fei; Fan, Ying; Luo, Yang; Cai, Ruigang; Zhang, Pin; Li, Qing; Xu, Binghe
	2014
会议名称	JOURNAL OF CLINICAL ONCOLOGY
会议日期	2014-05-20
收录类别	CPCI-S
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/6681112
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yuan, Peng,Wang, Jiayu,Ma, Fei,et al. Comparison of six cycles of epirubicin and paclitaxel (ET) versus four cycles of epirubicin and cyclophosphamide, followed by four cycles of paclitaxel (EC-T) as adjuvant therapy for operable breast cancer in women with positive axillary nodes[C]. 见:JOURNAL OF CLINICAL ONCOLOGY. 2014-05-20.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。